Apolizumab

Jump to navigation Jump to search

Template:Drugbox-mab Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.[1]

References

  1. Bayes M, Rabasseda X, Prous J (2003). "Gateways to clinical trials". Methods Find Exp Clin Pharmacol. 25 (9): 747–71. PMID 14685303.

Template:Humanizedmonoclonals